Abstract
We herein report a 78-year-old woman with Gaucher disease (GD) who was initially diagnosed with GD type 1, had been receiving long-term enzyme replacement therapy since 58 years old, and developed neurological manifestations in her 70s. The neurological manifestations included myoclonic seizures and progressive cognitive decline. Although it is rare for GD patients to first develop neurologic manifestations at such an advanced age, physicians engaged in long-term care for GD patients should be alert for this possibility.
Author supplied keywords
Cite
CITATION STYLE
Yamaguchi-Takegami, N., Takahashi, A., Mitsui, J., Sugiyama, Y., Chikada, A., Porto, K. J. L., … Toda, T. (2024). Late-onset Myoclonic Seizure in a 78-year-old Woman with Gaucher Disease. Internal Medicine, 63(6), 861–865. https://doi.org/10.2169/internalmedicine.1699-23
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.